181 related articles for article (PubMed ID: 34679752)
1. FRI-1 Is an Anti-Cancer Isoquinolinequinone That Inhibits the Mitochondrial Bioenergetics and Blocks Metabolic Shifts by Redox Disruption in Breast Cancer Cells.
Córdova-Delgado M; Fuentes-Retamal S; Palominos C; López-Torres C; Guzmán-Rivera D; Ramírez-Rodríguez O; Araya-Maturana R; Urra FA
Antioxidants (Basel); 2021 Oct; 10(10):. PubMed ID: 34679752
[TBL] [Abstract][Full Text] [Related]
2. A paraguayan toad Rhinella schneideri preparation based on Mbya tradition increases mitochondrial bioenergetics with migrastatic effects dependent on AMPK in breast cancer cells.
Schmeda-Hirschmann G; Burgos-Edwards A; Rojas de Arias A; López-Torres C; Palominos C; Fuentes-Retamal S; Herrera Y; Dubois-Camacho K; Urra FA
J Ethnopharmacol; 2022 Aug; 294():115344. PubMed ID: 35526731
[TBL] [Abstract][Full Text] [Related]
3. Complex Mitochondrial Dysfunction Induced by TPP
Fuentes-Retamal S; Sandoval-Acuña C; Peredo-Silva L; Guzmán-Rivera D; Pavani M; Torrealba N; Truksa J; Castro-Castillo V; Catalán M; Kemmerling U; Urra FA; Ferreira J
Cells; 2020 Feb; 9(2):. PubMed ID: 32053908
[TBL] [Abstract][Full Text] [Related]
4. Induction of mitochondrial reactive oxygen species production by GSH mediated S-glutathionylation of 2-oxoglutarate dehydrogenase.
Mailloux RJ; Craig Ayre D; Christian SL
Redox Biol; 2016 Aug; 8():285-97. PubMed ID: 26928132
[TBL] [Abstract][Full Text] [Related]
5. OGDH mediates the inhibition of SIRT5 on cell proliferation and migration of gastric cancer.
Lu X; Yang P; Zhao X; Jiang M; Hu S; Ouyang Y; Zeng L; Wu J
Exp Cell Res; 2019 Sep; 382(2):111483. PubMed ID: 31247190
[TBL] [Abstract][Full Text] [Related]
6. Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
Carlisle SM; Trainor PJ; Doll MA; Stepp MW; Klinge CM; Hein DW
Mol Carcinog; 2018 Nov; 57(11):1458-1466. PubMed ID: 29964355
[TBL] [Abstract][Full Text] [Related]
7. 2-Oxoglutarate dehydrogenase is a more significant source of O2(·-)/H2O2 than pyruvate dehydrogenase in cardiac and liver tissue.
Mailloux RJ; Gardiner D; O'Brien M
Free Radic Biol Med; 2016 Aug; 97():501-512. PubMed ID: 27394173
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mitochondrial 2-oxoglutarate dehydrogenase impairs viability of cancer cells in a cell-specific metabolism-dependent manner.
Bunik VI; Mkrtchyan G; Grabarska A; Oppermann H; Daloso D; Araujo WL; Juszczak M; Rzeski W; Bettendorff L; Fernie AR; Meixensberger J; Stepulak A; Gaunitz F
Oncotarget; 2016 May; 7(18):26400-21. PubMed ID: 27027236
[TBL] [Abstract][Full Text] [Related]
9. Anacardic Acid, Salicylic Acid, and Oleic Acid Differentially Alter Cellular Bioenergetic Function in Breast Cancer Cells.
Radde BN; Alizadeh-Rad N; Price SM; Schultz DJ; Klinge CM
J Cell Biochem; 2016 Nov; 117(11):2521-32. PubMed ID: 26990649
[TBL] [Abstract][Full Text] [Related]
10. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
[TBL] [Abstract][Full Text] [Related]
11. The 2-oxoacid dehydrogenase complexes in mitochondria can produce superoxide/hydrogen peroxide at much higher rates than complex I.
Quinlan CL; Goncalves RL; Hey-Mogensen M; Yadava N; Bunik VI; Brand MD
J Biol Chem; 2014 Mar; 289(12):8312-25. PubMed ID: 24515115
[TBL] [Abstract][Full Text] [Related]
12. A New Quinone-Based Inhibitor of Mitochondrial Complex I in D-Conformation, Producing Invasion Reduction and Sensitization to Venetoclax in Breast Cancer Cells.
Monroy-Cárdenas M; Andrades V; Almarza C; Vera MJ; Martínez J; Pulgar R; Amalraj J; Araya-Maturana R; Urra FA
Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627592
[TBL] [Abstract][Full Text] [Related]
13. Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.
Prinz C; Vasyutina E; Lohmann G; Schrader A; Romanski S; Hirschhäuser C; Mayer P; Frias C; Herling CD; Hallek M; Schmalz HG; Prokop A; Mougiakakos D; Herling M
Mol Cancer; 2015 Jun; 14():114. PubMed ID: 26041471
[TBL] [Abstract][Full Text] [Related]
14. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
[TBL] [Abstract][Full Text] [Related]
15. Protein S-glutathionylation alters superoxide/hydrogen peroxide emission from pyruvate dehydrogenase complex.
O'Brien M; Chalker J; Slade L; Gardiner D; Mailloux RJ
Free Radic Biol Med; 2017 May; 106():302-314. PubMed ID: 28242228
[TBL] [Abstract][Full Text] [Related]
16. Availability of the key metabolic substrates dictates the respiratory response of cancer cells to the mitochondrial uncoupling.
Zhdanov AV; Waters AH; Golubeva AV; Dmitriev RI; Papkovsky DB
Biochim Biophys Acta; 2014 Jan; 1837(1):51-62. PubMed ID: 23891695
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly.
Hinchy EC; Gruszczyk AV; Willows R; Navaratnam N; Hall AR; Bates G; Bright TP; Krieg T; Carling D; Murphy MP
J Biol Chem; 2018 Nov; 293(44):17208-17217. PubMed ID: 30232152
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial thiol modification by a targeted electrophile inhibits metabolism in breast adenocarcinoma cells by inhibiting enzyme activity and protein levels.
Smith MR; Vayalil PK; Zhou F; Benavides GA; Beggs RR; Golzarian H; Nijampatnam B; Oliver PG; Smith RA; Murphy MP; Velu SE; Landar A
Redox Biol; 2016 Aug; 8():136-48. PubMed ID: 26774751
[TBL] [Abstract][Full Text] [Related]
19. Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.
Bakalova R; Semkova S; Ivanova D; Zhelev Z; Miller T; Takeshima T; Shibata S; Lazarova D; Aoki I; Higashi T
Oxid Med Cell Longev; 2020; 2020():6212935. PubMed ID: 33204397
[TBL] [Abstract][Full Text] [Related]
20. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
